Breaking News

BioDuro Opens Shanghai Lab

May 15, 2013

Expands discovery services in Asia Pacific

BioDuro, a PPD Company, has opened a new lab in Shanghai, expanding its drug discovery services in Asia Pacific. The new lab is located in the Waigaoqiao Free Trade Zone, close to local and multinational pharmaceutical and biotechnology companies in Shanghai.
 
The 72,000-sq.-ft. lab, along with 20,000 sq. ft. of office space, offers drug metabolism and pharmacokinetic (DMPK), bioanalytical, chemistry, discovery biology and oncology pharmacology services. Clients also are able to take advantage of PPD’s clinical research services, as well as its library of assays.
 
“As a fully integrated life science research service provider, BioDuro has an experienced team of researchers and scientists with expertise in a wide range of drug discovery services,” said Jasmine Cui, Ph.D., general manager and chief scientific officer of BioDuro. “This new lab will allow us to meet the business needs of our clients more effectively by streamlining the discovery and development process, and continuing to enhance continuity and smooth transitions throughout the stages of development.”
  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • Limiting APIs in Manufacturing Effluent

    Limiting APIs in Manufacturing Effluent

    Joan Tell, Robert Drinane, Bruce Naumann, Jessica Vestel, and Gregory Gagliano, Merck & Co., Inc.||June 2, 2016
    An approach for setting limits on pharmaceuticals discharged in manufacturing effluent

  • Biopharma CMO Market Trends

    Biopharma CMO Market Trends

    Tim Wright, Editor||June 2, 2016
    Continued strong growth in biopharma industry is being driven by biosimilars